<DOC>
	<DOCNO>NCT00775203</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy , safety clinical benefit Trazodone Contramid® OAD ( Once A Day ) treatment Unipolar Major Depressive Disorder ( MDD ) .</brief_summary>
	<brief_title>A Randomized , Double-blind , Two-arm Study Comparing Efficacy Safety Trazodone Contramid® OAD Placebo Treatment Unipolar Major Depressive Disorder .</brief_title>
	<detailed_description>This two-arm , multicentre , randomize , placebo-controlled , double-blind , parallel-design study consist baseline phase ( screen wash-out ) double-blind randomize phase ( randomization Trazodone Contramid® OAD placebo ) . The total study duration include wash-out prohibit medication approximately 11 week ; total duration randomize phase 8 week ( titration : 2 week + treatment : 6 week ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>Males female . Aged 18 year old . Fulfills Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSMIV ) criteria Unipolar Major Depressive Disorder ( MDD ) ( Axis I ) confirm MiniInternational Neuropsychiatric Interview ( MINI ) . The primary DSMIV Axis I diagnosis MDD ( 296.22 , 296.23 , 296.32 , 296.33 ) ; subject meeting criterion another , non exclude Axis I disorder , must demonstrate MDD primary disorder . The current episode MDD last minimum 1 month , whether patient diagnose one single recurrent episode . Presence dysphoria day past four week . MontgomeryÅsberg Depression Rating Scale ( MADRS ) total score least 26 screen baseline . Oral write language comprehension level sufficient comply protocol complete studyrelated material . Sign date write Informed Consent Form ( ICF ) approve Research Ethic Board ( REB ) also sign dated Investigator prior study participation . DSMIV Major Depressive Disorder Specifiers : [ ] With Catatonic Features ; [ b ] With Postpartum Onset ; [ c ] With Seasonal Pattern ; Presence follow DSMIV Axis I disorder : generalize anxiety disorder , panic disorder , social phobia , obsessivecompulsive disorder , posttraumatic stress disorder , eat disorder , bipolar disorder , alcohol/substance abuse dependence ( caffeine nicotine allow ) , psychotic disorder . Depression secondary stroke , cancer severe medical illness . Positive urine drug screen screen visit . History present condition DSMIV Axis II disorder . History treatment refractory major depressive episode define incomplete therapeutic response two prior course least one month conventional antidepressant drug treatment adequate dosage . Currently psychotherapy ( least one session past month plan continue ) licensed/registered/certified mental health provider , marriage counselor , family therapist . Meet criterion high suicide risk MINI suicide scale , opinion investigator inappropriate trial due clinically significant suicidal homicidal potential . Require hospitalization treatment current episode depression . Uncorrected hypo hyperthyroidism . A history seizures pediatric febrile seizure . A history cardiac arrythmias require therapy . A history myocardial infarction within 1 year screening . Clinically significant abnormal finding Electrocardiography ( ECG ) , laboratory parameter . Unwilling discontinue use antidepressant , include herbal remedy , minimum 5 drug halflives prior screen . Unwilling discontinue use prohibit medication minimum 5 drug halflives prior screen . Treatment within last 3 week Monoamine Oxidase ( MAO ) inhibitor . Use follow concomitant treatment study : medication cause QT prolongation ( e.g . amiodarone , droperidol , erythromycin ) . medication cause PR prolongation ( e.g . digoxin ) . Anti psychotic ( e.g . haloperidol ) . protease inhibitor ritonavir indinavir . Hormonal treatment ( e.g . estrogen , oral contraceptive ) start within 3 month study entry . Treatment another investigational agent within last 30 day . Known documented allergy trazodone structurally similar drug . Previous failure treatment trazodone , previous discontinuation treatment trazodone due Adverse Events . Bowel disease cause malabsorption . Serious , unstable illness 3 month screen include limited : hepatic , renal , gastroenterologic , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic hematological disease . Pregnant lactating , childbearing potential willing use approve method contraception . Significant liver disease , define active hepatitis elevate liver enzymes &gt; 3 time upper boundary normal range . Significant renal disease , define Blood Urea Nitrogen ( BUN ) and/or creatinine &gt; 3 time upper boundary normal range clearance . Any condition , opinion investigator , would adversely affect patient 's ability complete study measure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Unipolar</keyword>
</DOC>